研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

高风险的黏膜型人乳头瘤病毒相关性手指鳞状细胞癌呈现出独特的临床病理特征和结果:一项双中心回顾性研究。

High-risk mucosal human papillomavirus-associated squamous cell carcinoma of the fingers presents distinctive clinicopathological characteristics and outcomes: a bicentric retrospective study.

发表日期:2022 Nov 23
作者: Ignasi Marti-Marti, Xavier Bosch-Amate, Daniel Morgado-Carrasco, Raquel Albero-González, Angel Santos-Briz, Laura Puebla-Tornero, Leonor Revelles-Peñas, Javier Cañueto, Llúcia Alòs, Agustí Toll
来源: CLINICAL AND EXPERIMENTAL DERMATOLOGY

摘要:

高危粘膜型人乳头瘤病毒(HR-HPV)似乎在皮肤鳞状细胞癌(cSCC)中起着一定的作用,尤其是在指甲肿瘤中,其中已经有人提出了生殖周数传播的假设。需要澄清HR-HPV在手指非指甲cSCC中的作用。为了评估HR-HPV在手指cSCC中的流行率、临床病理学特征、替代指标和结局。这是一项观察性双中心研究,包括患有位于手指上的原位或侵袭性cSCC的患者。评估了HR-HPV和非HR-HPV肿瘤之间的差异。共计45位患者(45个肿瘤)被纳入研究。在这些患者中,33%的病例检测到了HR-HPV(其中22%为HPV类型16)。HR-HPV患者的平均年龄较低,低于非HR-HPV患者(62.4岁 vs. 81.1岁,P=0.001)。HR-HPV肿瘤较小(10毫米 vs. 15毫米,P=0.07),更频繁地表现为皮内型(60% vs. 20%,P=0.004)。弹性纤维缺失(P=0.030)和炎症缺失(P=0.026),以及基底细胞样形态(P=0.003)是HR-HPV检测的代用品。HR-HPV肿瘤的p16阳性率平均为61%,而非HR-HPV肿瘤的p16阳性率为36%(P=0.061)。手术后的复发在HR-HPV肿瘤中较常见(58% vs. 34%),尽管这并没有统计学意义。在非指甲的肿瘤中,检测到了27%的HR-HPV。与非HR-HPV肿瘤相比,与HR-HPV相关的手指cSCC出现在年龄较轻的患者身上,肿瘤较小且渗透性较少。基底样形态的存在以及弹性纤维和炎症的缺失可用作HR-HPV检测的标志。在非指甲的cSCC中,HR-HPV的高流行率表明其在这些肿瘤的发病和病理机制中起着作用。©2022年作者。由牛津大学出版社代表英国皮肤科医师协会出版。保留所有权利。有关权限,请发送电子邮件至:journals.permissions@oup.com。
High-risk mucosal human papillomavirus (HR-HPV) seems to play a role in cutaneous squamous cell carcinoma (cSCC), particularly in nail tumours, where genitodigital transmission has been suggested. The role of HR-HPV in nonungual cSCC of the finger needs to be clarified.To evaluate the prevalence, clinicopathological characteristics, surrogates and outcomes of HR-HPV in cSCC of the finger.This was an observational bicentric study including patients with an excised in situ or invasive cSCC located on the finger. Differences in HR-HPV and non-HR-HPV tumours were evaluated.Forty-five patients (45 tumours) were included. HR-HPV was detected in 33% of cases (22% HPV type 16). The mean age was lower in patients with HR-HPV than in those with non-HR-HPV (62·4 vs. 81·1 years, P = 0·001). HR-HPV tumours were smaller (10 mm vs. 15 mm, P = 0·07) and more frequently intraepidermal (60% vs. 20%, P = 0·004). The absence of elastosis (P = 0·030) and inflammation (P = 0·026) and the presence of basaloid morphology (P = 0·003) were surrogates of HR-HPV detection. Mean p16 positivity was 61% in HR-HPV and 36% in non-HR-HPV tumours (P = 0·061). Recurrence after surgery was more common in HR-HPV tumours (58% vs. 34%), although this was not statistically significant. HR-HPV was detected in 27% of the nonungual tumours.HR-HPV-associated cSCC of the finger appears in younger patients, is smaller and is less infiltrative than non-HR-HPV tumours. The presence of a basaloid morphology and the absence of elastosis and inflammation could be used as markers for HR-HPV detection. The high prevalence of HR-HPV in nonungual cSCC suggests its aetiopathogenic role in these tumours.© The Author(s) 2022. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.